The weight loss peptide space is the most talked about — and most misunderstood — area in the field. This hub cuts through the noise with plain-language guides to how GLP-1 medications actually work, what the clinical evidence really shows, and what realistic outcomes look like. No hype, no shortcuts.
GLP-1 is a hormone your gut naturally produces after eating. This guide explains how medications like semaglutide and tirzepatide amplify that signal to reduce appetite and produce meaningful, sustained weight loss.
read more
Both are GLP-1-based medications, but they work differently and produce different results. A plain-language comparison of mechanisms, clinical outcomes, side effects, and who each one suits best.
read more
Around 25% of weight lost on GLP-1 medications comes from lean mass. This guide explains why it happens and the evidence-backed strategies for preserving muscle during treatment.
read more
The honest answer depends on which peptide and what you're measuring. This guide maps realistic timelines from first effects in weeks one to two through to meaningful body composition changes at three to six months.
read more
Ozempic is a peptide — but not all peptides are Ozempic. This guide untangles the confusion between GLP-1 prescription medications and the broader peptide category.
read more
GLP-1 agonists aren't the only peptides with evidence behind them for fat loss. This guide maps the main options by mechanism, evidence level, and appropriate use case.
read more
Clinical trials show impressive numbers. Real-world results are more nuanced. This guide sets honest expectations for timelines, response variation, and what factors most influence your outcome.
read more